Comparison of Esnoper® implant placement in non penetrating deep sclerectomy

• Published in: Acta ophthalmologica (Oxford, England) England), 2013-08, Vol.91 (s252), p.0-0
• Main Authors: IBANEZ, J, PéREZ GARCíA, D, ASCASO PUYUELO, FJ, CRISTóBAL BESCóS, JA
• Format: Article
• Language: English
• Subjects: Ophthalmology
• ISSN: 1755-375X; 1755-3768
• DOI: 10.1111/j.1755-3768.2013.T048.x

Purpose To compare the efficacy and safety of the Esnoper® implant in non penetrating deep sclerectomy (NPDS) with the implant placed in two different positions: under the scleral flap (in the scleral lake) versus a portion of the implant introduced in the suprachoroidal space. Methods Retrospective analysis of 40 eyes of 30 patients who underwent NPDS, being the implant Esnoper® placed under the scleral flap in Group A (22 eyes) and a part of it in suprachoroidal space in Group B (18 eyes). Results In group A, the IOP decreased from 22,8± 4,2 mmHg to 15,1 ±2,9 mmHg and a group B from 23,4±3,1 mmHg to 13,9 ±3,1 mmHg (p< 0,05). The difference in the postoperative IOP between both groups was stadistically non significant (p>0,05). Anti‐glaucoma medications decreased from 2,81±0,5 to 0,8±0,1 in group A, and from 2,9±0,5 to 0,2± 0,4 in group B, being this difference stadistically significant (p